Medicine & Life Sciences
Aedes
13%
Angola
24%
Animals
6%
Anopheles
28%
Anti-Bacterial Agents
9%
Antibodies
6%
Antigens
6%
Antimalarials
19%
Arboviruses
9%
artemisinine
8%
Babesia
7%
Bacteria
8%
Brazil
27%
Cabo Verde
18%
Canidae
14%
carbamoylpyridoxal 5'-phosphate
7%
Cats
6%
Child
8%
Chloroquine
11%
Coinfection
6%
Cross-Sectional Studies
8%
Culex
6%
Culicidae
32%
Delivery of Health Care
12%
Dengue
9%
Diptera
8%
Disease Outbreaks
9%
DNA
7%
Dogs
15%
Drug Resistance
21%
Epidemics
10%
Epidemiology
5%
Ethidium
11%
Extensively Drug-Resistant Tuberculosis
6%
Foraminifera
10%
Genes
14%
Genetic Variation
12%
Genome
11%
Genotype
10%
Global Health
7%
Guinea-Bissau
16%
Health
32%
Health Policy
7%
Health Services
7%
Health Workforce
11%
Hepatitis Delta Virus
7%
HIV
24%
HIV Infections
6%
HIV-1
17%
HIV-2
7%
In Vitro Techniques
9%
Income
6%
Infections
25%
Insecticide Resistance
7%
Islands
12%
Leishmania
18%
Leishmania infantum
29%
Leishmaniasis
26%
Malaria
42%
Mosquito Vectors
8%
Mozambique
32%
Multidrug-Resistant Tuberculosis
12%
Mutation
15%
Mycobacterium
6%
Mycobacterium tuberculosis
27%
Pandemics
14%
Parasites
39%
Parasitic Diseases
7%
Pharmaceutical Preparations
17%
Phenothiazines
7%
Phlebotomus
7%
Plasmodium
10%
Plasmodium chabaudi
7%
Plasmodium falciparum
22%
Plasmodium vivax
8%
Pneumocystis carinii
8%
Pneumocystis Pneumonia
8%
Polymerase Chain Reaction
12%
Population
19%
Portugal
100%
Primary Health Care
7%
Psychodidae
13%
Public Health
15%
Rhipicephalus
8%
Sexual and Gender Minorities
8%
Single Nucleotide Polymorphism
6%
Staphylococcus aureus
7%
Telemedicine
6%
Therapeutics
8%
Thioridazine
10%
Ticks
17%
Trypanosoma cruzi
5%
Tuberculosis
22%
Vaccines
8%
Viruses
9%
Visceral Leishmaniasis
11%
Western Africa
10%
Workforce
11%
Zika Virus
5%
Zoonoses
9%
Agriculture & Biology
Aedes aegypti
5%
Angola
8%
Anopheles
5%
Anopheles gambiae
17%
antibodies
5%
antimalarials
12%
arboviruses
5%
artemisinin
7%
blood
6%
Brazil
5%
cats
6%
chloroquine
9%
Culicidae
25%
DNA
5%
dogs
19%
drug resistance
7%
drugs
7%
genes
7%
genetic variation
7%
Guinea-Bissau
6%
Human immunodeficiency virus 1
5%
infection
21%
Leishmania
16%
Leishmania infantum
24%
leishmaniasis
21%
malaria
36%
monitoring
5%
Mozambique
12%
mutation
9%
parasites
27%
Phlebotominae
11%
Plasmodium
10%
Plasmodium chabaudi
6%
Plasmodium falciparum
21%
Plasmodium vivax
6%
Portugal
33%
public health
5%
sampling
7%
therapeutics
5%
ticks
10%
Trypanosoma cruzi
5%
visceral leishmaniasis
7%
Western Africa
6%
Social Sciences
Angola
7%
Brazil
11%
Cape Verde
6%
contagious disease
6%
cross-sectional study
5%
determinants
5%
Guinea-Bissau
7%
health
27%
health care
6%
health service
7%
Healthcare
9%
human resources
7%
immigrant
5%
Mozambique
12%
Portugal
34%
public health
7%